Cannabinoids for the treatment of dementia. (2009).
Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer’s disease. (2011).

Cannabinoids for treatment of Alzheimer’s disease: moving toward the clinic. (2014).

Author(s): Ester Aso, and Isidre Ferrer.

The cannabinoid compounds have polyvalent properties for the treatment of Alzheimer’s disease, which together promote progress towards a clinical trial. View study